T R Nansel1, L M Lipsky, R J Iannotti. 1. Prevention Research Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, United States. nanselt@mail.nih.gov
Abstract
AIMS: Weight gain is an oft-cited outcome of improved glycemic control in adults with type 1 diabetes, though few studies have investigated this in youth. The purpose of this paper was to examine cross-sectional and longitudinal associations of body mass index (BMI, kg/m(2)) with glycemic control in youth with type 1 diabetes (n=340, 12.5 ± 1.7 year, 49% female, duration ≥ 1 year) participating in a 2-year multi-center intervention study targeting family diabetes management. METHODS: BMI was calculated from height and weight measured at clinic visits. Glycohemoglobin (HbA1c) at each visit was assayed centrally. Cross-sectional associations of baseline BMI with glycemic control, and of change in BMI and HbA1c with baseline values, were examined. Longitudinal associations of time-varying BMI and HbA1c were examined using a multilevel linear mixed effects model controlling for time-varying time (months), insulin dose (units/kg/day), regimen, Tanner stage, and time invariant baseline diabetes duration, BMI, treatment group and sociodemographic characteristics. RESULTS: Baseline HbA1c was unrelated to baseline BMI, but was related positively to subsequent BMI change (p=0.04) and inversely to HbA1c change (p=0.002). Baseline BMI was inversely related to BMI change (p=0.01) and unrelated to HbA1c change. In multilevel regression, BMI was related inversely to HbA1c (%) (β ± SE=-0.11 ± 0.02, p<0.001) and positively to insulin dose (0.23 ± 0.07, p=0.001). In the treatment group only, BMI was positively related to pump regimen (0.18 ± 0.08, p=0.02). CONCLUSIONS: Increased insulin administered to improve glycemic control may contribute to increased BMI in youth with type 1 diabetes, indicating the importance of determining ways to minimize weight gain while optimizing glycemic control. Published by Elsevier Ireland Ltd.
AIMS: Weight gain is an oft-cited outcome of improved glycemic control in adults with type 1 diabetes, though few studies have investigated this in youth. The purpose of this paper was to examine cross-sectional and longitudinal associations of body mass index (BMI, kg/m(2)) with glycemic control in youth with type 1 diabetes (n=340, 12.5 ± 1.7 year, 49% female, duration ≥ 1 year) participating in a 2-year multi-center intervention study targeting family diabetes management. METHODS: BMI was calculated from height and weight measured at clinic visits. Glycohemoglobin (HbA1c) at each visit was assayed centrally. Cross-sectional associations of baseline BMI with glycemic control, and of change in BMI and HbA1c with baseline values, were examined. Longitudinal associations of time-varying BMI and HbA1c were examined using a multilevel linear mixed effects model controlling for time-varying time (months), insulin dose (units/kg/day), regimen, Tanner stage, and time invariant baseline diabetes duration, BMI, treatment group and sociodemographic characteristics. RESULTS: Baseline HbA1c was unrelated to baseline BMI, but was related positively to subsequent BMI change (p=0.04) and inversely to HbA1c change (p=0.002). Baseline BMI was inversely related to BMI change (p=0.01) and unrelated to HbA1c change. In multilevel regression, BMI was related inversely to HbA1c (%) (β ± SE=-0.11 ± 0.02, p<0.001) and positively to insulin dose (0.23 ± 0.07, p=0.001). In the treatment group only, BMI was positively related to pump regimen (0.18 ± 0.08, p=0.02). CONCLUSIONS: Increased insulin administered to improve glycemic control may contribute to increased BMI in youth with type 1 diabetes, indicating the importance of determining ways to minimize weight gain while optimizing glycemic control. Published by Elsevier Ireland Ltd.
Authors: Reinhard W Holl; Peter G F Swift; Henrik B Mortensen; Helle Lynggaard; Phillip Hougaard; Henk-Jan Aanstoot; Francesco Chiarelli; Denis Daneman; Thomas Danne; Harry Dorchy; Patrick Garandeau; Steven Greene; Hilary M C V Hoey; Eero A Kaprio; Mirjana Kocova; Pedro Martul; Nobuo Matsuura; Kenneth J Robertson; Eugen J Schoenle; Oddmund Sovik; Rosa-Maria Tsou; Maurizio Vanelli; Jan Aman Journal: Eur J Pediatr Date: 2002-11-26 Impact factor: 3.183
Authors: Kimberly A Driscoll; Karen D Corbin; David M Maahs; Richard Pratley; Franziska K Bishop; Anna Kahkoska; Korey K Hood; Elizabeth Mayer-Davis Journal: Curr Diab Rep Date: 2017-08 Impact factor: 4.810
Authors: Angelica Cristello Sarteau; Anna R Kahkoska; Jamie Crandell; Daria Igudesman; Karen D Corbin; Jessica C Kichler; David M Maahs; Frank Muntis; Richard Pratley; Michael Seid; Dessi Zaharieva; Elizabeth Mayer-Davis Journal: Pediatr Res Date: 2022-06-22 Impact factor: 3.756
Authors: Anna R Kahkoska; Christina M Shay; Sarah C Couch; Jamie Crandell; Dana Dabelea; Evgenia Gourgari; Jean M Lawrence; Angela D Liese; Catherine Pihoker; Beth A Reboussin; Natalie The; Elizabeth J Mayer-Davis Journal: Pediatr Diabetes Date: 2018-09-14 Impact factor: 3.409
Authors: Anna R Kahkoska; Crystal T Nguyen; Linda A Adair; Allison E Aiello; Kyle S Burger; John B Buse; Dana Dabelea; Lawrence M Dolan; Faisal S Malik; Amy K Mottl; Catherine Pihoker; Beth A Reboussin; Katherine A Sauder; Michael R Kosorok; Elizabeth J Mayer-Davis Journal: J Clin Endocrinol Metab Date: 2019-12-01 Impact factor: 6.134